Compare SERA & AEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SERA | AEI |
|---|---|---|
| Founded | 2008 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Precision Instruments | Building operators |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 130.5M | 132.7M |
| IPO Year | 2021 | N/A |
| Metric | SERA | AEI |
|---|---|---|
| Price | $3.57 | $2.93 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 68.1K | 43.7K |
| Earning Date | 11-13-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $95,000.00 | ★ $12,108,028.00 |
| Revenue This Year | $25.84 | N/A |
| Revenue Next Year | $347.37 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 1.06 | N/A |
| 52 Week Low | $1.37 | $0.70 |
| 52 Week High | $6.92 | $4.55 |
| Indicator | SERA | AEI |
|---|---|---|
| Relative Strength Index (RSI) | 57.21 | 49.25 |
| Support Level | $3.44 | $3.05 |
| Resistance Level | $3.85 | $3.98 |
| Average True Range (ATR) | 0.27 | 0.41 |
| MACD | 0.04 | -0.01 |
| Stochastic Oscillator | 73.33 | 38.95 |
Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.
Alset Inc is a diversified holding company engaged through its subsidiaries in the development of EHome communities and other real estate, financial services, digital transformation technologies, biohealth activities, and consumer products with operations in the United States, Singapore, Hong Kong, Australia, and South Korea. The Company operates in four business segments: real estate, digital transformation technology, Biohealth, and other business activities, and it derives a majority of its revenue from the Real Estate segment.